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Abstract
Around 50-60% of all cancer patients undergo radiation therapy. Although some patients show
complete response with no recurrence, a significant proportion of the population still develop
radiation resistance. It is important to identify tumor resistance at early stages of therapy in order
to adjust treatment protocol and avoid extra exposure to radiation. Current methods to assess
treatment response are only limited to anatomical measurements of tumor volume after therapy.
Novel approaches that shed the light on any functional information during the course of
radiotherapy could significantly improve our ability to identify patients who do not respond to
radiation therapy. Diffuse reflectance spectroscopy (DRS) is an optical fiber-based technique that
is capable of quantitative, nondestructive, and repeated measurements of tumor biology. Our aim
was to determine the sensitivity of DRS to escalating doses of radiation. An additional goal was to
determine DNA damage and changes in hypoxic fraction post-radiation, and to determine if these
immunohistochemical assessments were concordant with changes in optical properties, such as
tissue scattering, hemoglobin concentration, and vascular oxygenation. Lookup table (LUT)-based
model was used to fit the acquired DRS spectra and extract wavelength-dependent absorption and
scattering properties from tissue. Our results have shown that the measurements of tumor optical
properties such as oxygen saturation and total hemoglobin can provide reliable estimates of the
hypoxic state of tissue. Additionally, we present significant increase in hypoxic fraction between
control and irradiated groups.

Introduction
According to the American Cancer Society, about 268,600 new cases of invasive breast cancer
will be diagnosed in 2019. Radiation therapy is usually recommended after lumpectomy because
it lowers the risk of breast cancer recurrence1. Radiation therapy destroys cancerous cells by
depositing high-energy rays of photons (X-rays and gamma) or particles such as protons, neutrons
and alpha2. Radiation is commonly delivered through two mechanisms: externally using an outside
source such as cathode ray tubes, linear accelerator or cobalt machines (external beam radiation),
or internally by radioactive source inside the body using catheters or seeds (brachytherapy)3.

The overall outcome of radiation therapy is to cause functional abnormalities within the cell
through direct and indirect actions, which eventually kills tumor cells over weeks of treatment.
Presence of oxygen within cancerous cells is important to damage DNA and other macromolecules
which are essential for cell survival. Tumor cells have developed multiple strategies to resist
radiation damage. For instance, Hypoxia (𝑝𝑂2 < 10 mg/Hg) significantly affects the outcome of
radiation treatment and is associated with poor survival rates in cancer patient. Therefore, tumor
hypoxia has been studied as a potential marker of developing resistance to radiation therapy3.

At this moment, there is no accepted technique that would enable early detection of radiation
resistant tumors. Currently, imaging method used for assessing response to therapy such as
Positron Emission Tomography (PET) imaging of 18 F- Flurorodeoxy glucose (FDG) uptake or
MRI are expensive and does not allow repeated measurements 4. Moreover, PET imaging can be
used only 5 or 6 weeks after therapy due to the limitation of radiolabeled isotope. Therefore, there

is an urgent clinical need for a viable technique that identify patients having poor response to
radiation therapy on the early stage of the treatment5.

Current methods for measuring oxygen level within tissue are oxygen 𝑝𝑂2 microelectrodes, blood
oxygen level dependent (BOLD) Magnetic resonance imaging (MRI), dynamic contrast enhanced
(DCE)-MRI, PET imaging [18F]-labeled fluoromisonidazole (FMISO). The limitations of these
current techniques are invasiveness level, ability for frequent measurements, and indirect
assessment of tissue oxygen status. 𝑝𝑂2 microelectrodes are invasive, not capable of repeated
clinical measurements, and measures hypoxia over a limited area of the tissue. Both MRI
techniques provide indirect assessment of tissue oxygen level. Due to accumulation of FMISO
contrast agent in normal tissue, this technique cannot be repeated frequently6. In contrast, diffuse
reflectance spectroscopy (DRS) is an optical fiber technique which provides quantitative, nondestructive, and repeated measurements of tissue vascular oxygenation based on hemoglobin
absorption7.

In DRS, light is generated by a halogen lamp light source and sent to the tissue through optical
fiber probe. Fiber probe send the light from the source to the tissue and collect the reflected light
back from tissue. The separation between the source and detector optical fibers determine the
sampling depth. From the reflected light, tissue optical properties such as scattering, and
absorption can be measured. The main tissue components that contribute to absorption are melanin
in epidermis and hemoglobin located in blood vessels in the dermis. There are two types of
hemoglobin in blood: hemoglobin bound to oxygen (oxygenated 𝐻𝑏𝑂2 ),and unbound hemoglobin
(deoxygenated dHb). Based on Figure 1, oxygenated and deoxygenated hemoglobin have

distinguishable absorption spectra over a wavelength range of 500-600 nm. Oxygenated
hemoglobin has double peaks at 542 and 577 nm, while deoxygenated hemoglobin has a single
peak at 560 nm8.

Figure 1: Absorption spectra of tissue components mainly contributing to the absorption of light
in the range of 300-1000 nm: oxygenated hemoglobin(𝐻𝑏𝑂2 ), deoxygenated hemoglobin(dHb).

The vascular oxygenation (𝑆𝑂2 )can be quantified by calculating the ratio between oxygenated
and total hemoglobin concentration as shown in equation 1:
𝑆𝑂2 =

𝐻𝑏𝑂2
𝐻𝑏𝑂2 +𝑑𝐻𝑏

× 100%

equ.(1)

Absorption is described using an absorption coefficient 𝜇𝑎 (𝜆) as the following:
𝜇𝑎 (𝜆) = [𝑐𝐻𝑏] [𝛼 𝜀𝐻𝑏𝑂2 (𝜆) + (1 − 𝛼)𝜀𝑑𝐻𝑏 (𝜆)] + 𝜀𝑚𝑒𝑙 (𝜆)𝑐𝑚𝑒𝑙 equ. (2)

Where

𝑐𝐻𝑏

is

total

hemoglobin

concentration,

𝛼

is

oxygen

saturation,

𝜀𝐻𝑏𝑂2 (𝜆), 𝜀𝑑𝐻𝑏 (𝜆), 𝜀𝑚𝑒𝑙 (𝜆) are the molar extinction coefficients of oxygenated hemoglobin,

deoxygenated hemoglobin and melanin, respectively. Similarly, scattering due to collagen,
mitochondria, and nuclei can be described by scattering coefficient 𝜇′𝑠 (𝜆)as given in equation 3:
𝜆

𝜇′𝑠 (𝜆) = 𝜇𝑠′ (𝜆) + ( )−𝐵 equ.(3)
𝜆0

Where 𝜆0 = 630 𝑛𝑚, and B is the scattering power related to scattering particle size.
Consequently, reflectance is calculated as the ratio between the intensity of reflected light to that
of the incident light 9. DRS accuracy and sensitivity are mainly dependent on two factors: fiber
optic probe source-detector separation, and lookup table LUT- based inverse model to extract
optical parameters10.

The goal of this study is to determine the sensitivity of DRS to change in tumor oxygenation
immediately after radiation. To achieve this goal, three aims were established:
1. Determine dose-dependent changes in tumor oxygenation using escalating doses of
radiation (2Gy, 8Gy).
2. Determine depth-dependent radiation response using fiber optic probes with different
source-detector separations.
3. Determine the correlation between immunohistochemical assessment of hypoxia and DRS
optical properties after radiation.

Methods
Cell Culture and Tumor Xenograft
All studies and protocols were approved by the Institutional Animal Care & Use Committee
(IACUC) of the University of Arkansas. Twenty-one balb/c mice were kept under standard 12
hours light and dark cycles at the Central Laboratory Animal Facility (CLAF). 4T1 murine
mammary adenocarcinoma cells were injected into the mice (500,000 cells in 100 μl) to grow
subcutaneous tumor xenografts. When the tumor volume reached 200 𝑚𝑚3 , DRS measurements
were acquired on all mice. Tumors were excised from 5 mice in the control group. The other 16
mice were distributed into two groups to undergo radiation of 2 Gy (n = 10) and 8 Gy (n=6),
respectively. Immediately after radiation, DRS spectra were recorded and mice were injected with
pimonidazole, an established hypoxia marker (60 mg/kg, solution of 12 mg/ml). About 60 minutes
post-injection, tumors were excised and snap-frozen in OCT compound.

Quantification of tissue optical properties
DRS consists of halogen lamp (HL-2000, Ocean Optics, Dunedin, Florida) as a light source, a
USB spectrometer (Flame, Ocean Optics) for acquisition, and a fiber optic probe of source-detector
separation of 1.5 mm and 2.25 mm as shown in figure 2. An established lookup table-based model
(LUT) was used to quantify optical properties of tumor such as vascular oxygenation, hemoglobin
concentration, and tissue scattering.

Figure 2: (A) Experimental setup of DRS and (B) bifurcated fiber optic probe illustrating the
common tissue end, the source end that is connected to the light source, and the detector end that
is connected to the USB spectrometer.

Immunohistochemical Assessment
Frozen tumors were stored -80 C and were sliced into sections of 10 μm using a cryotome (CM
1850; leica, Inc., Nussloch, Germany). Based on the source-detector separation of 1.5 and 2.25
mm, tumor slices were obtained at depth ranges of (0.8-1.2 mm) and (1.4-1.8 mm), respectively.
Direct labeling protocol was followed to stain with antibodies targeted to pimonidazole. First,
slices were fixed with 4 % PFA, washed for three times with PBS (3 seconds each), and
permeabilized with 0.1% Triton-X. Next, it was washed and incubated with blocking solution
(95% PBS, 4% goat serum, and 1% sodium azide) for an hour in room temperature. Then, it was
stained with primary antibody (Hypoxyprobe Red549 kit; HPI, Inc., Burlington, Massachusetts)
for an hour in a dark room. After rinsing with PBS, slides were covered with fluoromount and
stored in room temperature overnight for imaging.

Image and statistical Analysis
MATLAB (Mathworks; Natick, Massachusetts) was used to analyze immunofluorescence images
at the specified depth ranges. First, each single image was converted into a grayscale image to find
the local threshold using Otsu’s method11. Then, global threshold was calculated. Hypoxic fraction
was computed by finding the ratio of segmented pixels (hypoxic) to the total pixels in tissue. All
statistical analysis was performed using JMP (SAS, Cary, NC). Two-way ANOVA test was
utilized to determine changes in hypoxic fraction of the three groups of interest at different depths.
Linear correlation test was conducted to determine the relation between the optical properties and
the immunohistochemical outcomes.

Results & Discussion
Figure 3a presents DRS spectra from control, 2 Gy, and 8 Gy groups which were collected when
tumor volume reached 200 𝑚𝑚3 . Similarly, Figure 3b presents wavelength-dependent absorption
coefficient extracted from LUT model fit to DRS spectra. Our findings show the double peaks of
at 542 and 577 nm appear less prominent in irradiated groups of 2 Gy and 8 Gy, which indicates
lower levels of vascular oxygenation.

Figure 3: (A) Representation in vivo DRS spectra and their LUT fits from control, 2Gy, 8Gy
groups at V=200 𝑚𝑚3 . (B) Corresponding wavelength-dependent absorption coefficients
determined from LUT fits to spectra.

Figure 4 represents the immunohistochemical images of hypoxic fraction in all of the three groups
of interest at different depth ranges. Our results have shown an increasing trend in hypoxic fraction
in response to radiation. We also investigated depth-dependent changes in hypoxia, but there was
not a significant relation between HF and depth.

Figure 4: Pimonidazole immunofluorescence image of (A) control with HF= 4.66%, (B) 2Gy
with HF= 14.67%, (C) 8Gy with HF= 21.95%. (D) Fold-change in hypoxia level of control, 2Gy,
and 8Gy group with depth of (0.8-1.2 mm, and 1.4-1.8 mm). Error bars represent standard
deviation. * represents p value <=0.05

Figure 5 presents the changes of oxygen saturation among the three groups of interests at depth
range of (0.8-1.2 mm) and (1.4-1.8 mm). Our findings show decreasing trend in oxygenation at
the irradiated groups of 2 Gy and 8 Gy.

Figure 5: Shows mean values of oxygen saturation sO2 (%) of control, 2Gy, 8Gy groups,
collected at source-detector separation of 1.5 and 2.25 mm. Error bars represent SEM.

Based on pimonidazole bound areas in tissue and vascular oxygen saturation detected with
quantitative optical Diffuse Reflectance Spectroscopy (DRS), a statistically significant negative
correlation was found between hypoxic fraction and vascular oxygenation as shown in figure 6.
Tumors with high oxygen saturation represents low hypoxic fraction and vice versa. These
findings support that vascular oxygenation measured using DRS are concordant with hypoxic
fraction and can be used as indirect indication of tumor oxygenation, which is consistent with
previous findings in a similar xenograft model9.

Figure 6: scatterplot representing the relationship between HF measure at depth of (0.8-1.2 mm)
and DRS-based measures of sO2 (%) collected at SD=1.5mm. Black solid line indicate
regression line with p=0.0395, R2=0.226.
Our future work includes plans to study time-dependent changes in tumor microenvironment in
response to escalating doses of radiation. Hypoxic fraction increases after the exposure to
radiation, we are currently investigating the mechanism behind this increase in hypoxia .

Conclusion
Radiation therapy has shown to be highly cost effective with a single modality treatment and
accounts for about 5% of the total cost of cancer treatments. As a result, any improvement in
radiation therapy efficiency will benefit a significant number of cancer patients. One of the main
challenges in the modern oncology is tumor resistance against radiation treatment. DRS is a
potential technique that may be used in assessing tumor response to radiation therapy at early
stages of the treatment. In this study, we found that there were no significant depth-dependent
changes in oxygen saturation or hypoxic fraction levels has been observed. However, there was

significant change in hypoxia in irritated groups of 2 Gy and 8 Gy. Monitoring vascular oxygenation
can provide clinical assessment of tumor microenvironment during the course of the treatment.
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